课题基金 / 基金详情

Investigation of mechanism of developing neonatal hypoxic ischemic encephalopathy establishment of novel therapy.

Investigation of mechanism of developing neonatal hypoxic ischemic encephalopathy establishment of novel therapy.
新生儿缺氧缺血性脑病发病机制探讨,建立新疗法。
批准号:
20790771
负责人:
FUJIOKA Hiroki
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, we found the expression of inducible nitric oxide synthase (iNOS) in neurons of severe neonatal hypoxic ischemic encephalopathy model piglets after 12 hours. Level of blood biopterin, known as a co-factor of iNOS, was also increased. The increase was inhibited by MK-801, one of NMDA receptor antagonist. However, expression of iNOS was not affected. Guanosine triphosphate cyclohydrolase I (GTPCH) is the rate-limiting enzyme of biopterin synthesis pathway. Previous reports described that proinflammatory cytokines up-regulated the activity of GTPCH. It was suggested that excitatory neurotransmission affected the synthesis of proinflammatory cytokines. On the other hand, rat model of status epilepticus by using kainic acid, an analogue of glutamate, indicated no increase of iNOS in neuron. Those results suggested that the pathways of signal transductions were different between swine and rodents.Human Segawa Disease was caused by the defect of GTPCH. Generally, biopterin shortage causes hyperphenylalaninemia. However blood phenylalanine concentration of Segawa disease patients was within normal range, for the mutations of GTPCH in Segawa disease were heterozygous. We compared blood phenylalanine levels between patients of Segawa disease and controls. The result was that the blood phenylalanine level in Segawa disease was within normal range however the values were significantly higher than those of controls.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T Yamano Usefulness of the plasma neopterin concentration in screening for dopa-responsive dystonia
T Yamano 血浆新蝶呤浓度在筛查多巴反应性肌张力障碍中的作用
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [H Fujioka, H Shintaku, S Kudo, T Sakaguchi]
通讯作者: T Sakaguchi
Plasma Phenylalanine Level in Dopa-Responsive Dystonia
多巴反应性肌张力障碍的血浆苯丙氨酸水平
DOI: --
发表时间: 2009
期刊: Movement Disorders 24(15)
影响因子: --
作者: [H Fujioka, et, al.]
通讯作者: al.
Tsunekazu Yamano Lower plasma neopterin concentration in dopa-responsive dystonia patients
Tsunekazu Yamano 降低多巴反应性肌张力障碍患者血浆新蝶呤浓度
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Hiroki Fujioka, Haruo Shintaku, Masaya Segawa, Satoshi Kudo]
通讯作者: Satoshi Kudo
NMDA受容体阻害剤が新生児の低酸素虚血に与える生化学的影響-新生仔ブタモデルを用いた検討-
NMDA受体抑制剂对新生儿缺氧缺血的生化作用 - 使用新生猪模型的研究 -
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [藤岡弘季, 他]
通讯作者:
7
    海外基金